Triumph Junheng (Bengbu) Co., Ltd Borosilicate glass needle tubes for Pre-fillable Syring have obtained Type I registration certification

Recently, the borosilicate glass needle tubes for Pre-fillable Syringe, declared by Triumph Junheng (Bengbu) Co., Ltd., have been successfully updated on the National Medical Products Administration's drug packaging materials registration platform. The registration status is officially marked as I, with registration number B2026000014 and an update date of March 13, 2026.

The successful approval of the I status registration marks that the technical documentation, production process, and quality standards of the company's product have completed the preliminary review by the national drug regulatory authority, meeting the requirements for the registration management of pharmaceutical packaging materials. This lays a solid foundation for subsequent joint review and approval with pharmaceutical preparations.


As the core production base for Triumph Junheng's expansion into the high-end pharmaceutical glass field, the Bengbu company has deeply invested in the research, development, and manufacturing of borosilicate glass needles for prefilled syringes, with product specifications ranging from 0.5 to 20ml. Relying on internationally advanced production processes and stringent quality control systems, it has achieved dual guarantees for product performance and quality. The implementation of I status registration not only serves as an authoritative certification of the company's product compliance and technical strength, but also lays a solid foundation for compliance as the company expands into the pharmaceutical packaging market and deepens supply chain cooperation, thereby enabling domestic high-end pharmaceutical packaging materials to better serve the needs of pharmaceutical companies both domestically and internationally.

In the future, Triumph JH Bengbu Co., Ltd. will continue to take the I-status registered products as a starting point, steadily advance the joint review work with pharmaceutical companies, continuously optimize production processes, enhance product performance, adhere to the safety bottom line of drug packaging materials, and provide more reliable packaging material support for the high-quality development of the pharmaceutical industry.